Clinical Rationale
This structured 10-week program is based on contemporary pain neuroscience and neuroplastic principles. It supports patients with persistent pain to:
- Improve pain self-efficacy
- Reduce disability and fear avoidance
- Regulate stress reactivity
- Improve mood–pain interactions
- Reduce reliance on opioid medication (in collaboration with GP)
The program is adjunctive to medical management and does not replace GP oversight.
Suitable Patients
Patients with:
- Chronic pain > 3 months
- Central sensitisation features
- Fibromyalgia, persistent spinal pain, post-surgical pain
- Ongoing opioid use and desire to reduce reliance
- Comorbid anxiety/depression associated with pain
- Repeated medical investigations with limited improvement
Not suitable for:
- Acute psychiatric instability
- Active substance misuse
- Significant cognitive impairment
Outcome Measures (Pre & Post)
- Pain Self-Efficacy Questionnaire (PSEQ)
- DASS-21
- Pain Catastrophising Scale
- Self-reported medication usage
Referrers receive a discharge summary including functional outcomes.
Funding Pathways
- Mental Health Care Plan (group therapy)
- WorkCover
- DVA
- Private payment + health fund rebate
Next Intake Dates
21st April
16th June
Referrals
Please send referral made out to Jan Gudkovs via:
Fax : 4667 1333 / Medical Objects /
